NCT05225467

Brief Summary

Rationale: During perioperative period, prolonged starvation, surgical stress, acute complications (e.g. infection) and medication changes all promote ketone generation, therefore increasing the risk of ketoacidosis. At present, there is no literature concerning the ketone production in patients undergoing cardiac surgery, regardless of the diabetes status. Objectives: The objectives of this study are to explore the change in blood ketone level during the perioperative period in patients with and without diabetes, to observe the incidence of perioperative ketoacidosis, and to investigate therapy and outcome of patients with perioperative ketoacidosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2023

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

January 5, 2022

Last Update Submit

July 19, 2023

Conditions

Keywords

SurgeryKetones

Outcome Measures

Primary Outcomes (1)

  • Blood ketone difference

    The primary outcome in this study is the difference in blood ketone level before and after cardiac surgery.

    During surgery

Secondary Outcomes (2)

  • Incidence of ketoacidosis

    Post surgery up to three days

  • Difference in ketone development between patient with and without diabetes mellitus.

    During Surgery

Other Outcomes (1)

  • Other

    Post surgery up to three days

Study Arms (1)

Main group

All participants taking part in this study are subsequently categorized in this group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for cardiac surgery with an on-pump procedure are eligible for inclusion. A total of 54 subjects will be enrolled.

You may qualify if:

  • Aged eighteen years or older
  • Scheduled for open heart surgery

You may not qualify if:

  • Diagnosed with type 1 diabetes mellitus or latent auto-immune diabetes in adults
  • Recently used sodium glucose transport co-enzyme 2 (SGLT-2i's) within 2 weeks before surgery)
  • History of recurrent ketoacidosis (two times or more within three months)
  • Emergency surgery
  • (Suspected) pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amsterdam University Medical Centre

Amsterdam-Zuidoost, North Holland, 1105 AZ, Netherlands

Location

Related Publications (8)

  • Vetter TR, Jones KA. Perioperative Surgical Home: Perspective II. Anesthesiol Clin. 2015 Dec;33(4):771-84. doi: 10.1016/j.anclin.2015.07.002.

    PMID: 26610629BACKGROUND
  • Meyer EJ, Mignone E, Hade A, Thiruvenkatarajan V, Bryant RV, Jesudason D. Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy. Diabetes Care. 2020 Nov;43(11):e181-e184. doi: 10.2337/dc20-1244. Epub 2020 Sep 17. No abstract available.

    PMID: 32943440BACKGROUND
  • Anderson JC, Mattar SG, Greenway FL, Lindquist RJ. Measuring ketone bodies for the monitoring of pathologic and therapeutic ketosis. Obes Sci Pract. 2021 May 4;7(5):646-656. doi: 10.1002/osp4.516. eCollection 2021 Oct.

    PMID: 34631141BACKGROUND
  • Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019 Jul;123(1):27-36. doi: 10.1016/j.bja.2019.03.028. Epub 2019 May 3.

    PMID: 31060732BACKGROUND
  • Blanco JC, Khatri A, Kifayat A, Cho R, Aronow WS. Starvation Ketoacidosis due to the Ketogenic Diet and Prolonged Fasting - A Possibly Dangerous Diet Trend. Am J Case Rep. 2019 Nov 22;20:1728-1731. doi: 10.12659/AJCR.917226.

    PMID: 31756175BACKGROUND
  • Dennhardt N, Beck C, Huber D, Sander B, Boehne M, Boethig D, Leffler A, Sumpelmann R. Optimized preoperative fasting times decrease ketone body concentration and stabilize mean arterial blood pressure during induction of anesthesia in children younger than 36 months: a prospective observational cohort study. Paediatr Anaesth. 2016 Aug;26(8):838-43. doi: 10.1111/pan.12943. Epub 2016 Jun 13.

    PMID: 27291355BACKGROUND
  • Ohkawa H, Iwakawa T, Ohtomo N, Kitayama M, Miyahara A, Ishihara H, Matsuki A. [Clinical study on intraoperative hyperketonemia in non-diabetic surgical patients under general anesthesia]. Masui. 1993 Dec;42(12):1803-7. Japanese.

    PMID: 8301829BACKGROUND
  • Polidori D, Iijima H, Goda M, Maruyama N, Inagaki N, Crawford PA. Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin. Diabetes Obes Metab. 2018 May;20(5):1321-1326. doi: 10.1111/dom.13224. Epub 2018 Feb 14.

    PMID: 29341404BACKGROUND

MeSH Terms

Conditions

KetosisDiabetic KetoacidosisDiabetes Mellitus

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesDiabetes ComplicationsEndocrine System DiseasesGlucose Metabolism Disorders

Study Officials

  • Jeroen Hermanides, dr

    Amsterdam Univeristy medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Physician

Study Record Dates

First Submitted

January 5, 2022

First Posted

February 4, 2022

Study Start

March 15, 2022

Primary Completion

March 17, 2023

Study Completion

March 18, 2023

Last Updated

July 20, 2023

Record last verified: 2023-07

Locations